Evidence map›Paper›PMID 40345047›Full record

ArticleInternational journal of surgery case reports2025

Unusual etiology of life-threatening retroperitoneal hemorrhage in an end-stage renal disease patient post-hemodialysis: Simultaneous rupture of renal and splenic artery aneurysms.

Meghdad Ghasemi Gorji, Helia Bazroodi, Sadra Soveid

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Meghdad Ghasemi GorjiDepartment of Vascular Surgery, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: meghdadghasemi@sums.ac.ir.
Helia BazroodiStudent Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: heliabazroodi@yahoo.com.
Sadra SoveidStudent Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSpontaneous retroperitoneal hemorrhage resulting from rupture of splenic artery and renal artery aneurysm is a rare but potentially lethal complication. PRESENTATION OF CASE: A 42-year-old man with a history of resistant hypertension and end-stage renal disease (ESRD) arrived at our hospital with an unstable condition accompanied by excruciating abdominal pain, brought on by a massive retroperitoneal hemorrhage resulting from ruptured renal and splenic artery aneurysm after his most recent hemodialysis session. Despite emergency surgery and optimal supportive cares, the patient unfortunately passed away. DISCUSSION: Renal artery aneurysm (RAA) is uncommon in patients who show no signs of predisposing variables such as systemic vasculitis or trauma. As far as we know, except for hypertension and ESRD, our patient had none of these risk factors. It is challenging to identify the relationship between RAA and hypertension because of its rarity. However, prior research thoroughly examined its co-occurrence with splenic and cerebral aneurysms, as our patient had experienced.

conclusionEven with the best surgical and non-surgical interventions, spontaneous aneurysmal rupture of the renal and splenic arteries can lead to high mortality rates. Therefore, greater caution should be undertaken to diagnose these aneurysms early.

Indexed as

End stage renal diseaseHemodialysisIntracranial hemorrhageRenal artery aneurysmResistant hypertensionSplenic artery aneurysm

Identifiers

PMID40345047
PMCPMC12136760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.